Top 4 High-Yield Dividend Stocks to Add to Your Portfolio

A low yield isn't always a safe yield... ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

AN OXFORD CLUB PUBLICATION

View in browser SPONSORED How Can YOU Target Winning Stocks With the Help of ChatGPT? In a recent backtest, the University of Florida showed that an investment strategy using ChatGPT produced 512% gains in 2022. Between 2014 and 2021, hedge funds proved investment strategies using AI could juice their returns by up to five times. Now, on September 13, world-renowned hedge fund manager Alpesh Patel will reveal... For the first time ever... The test results from his own ChatGPT-enhanced strategy. He says they can be summed up in one word... SHOCKING. Attend This FREE Online Event SAFETY NET Is This Company's Dividend in Danger? John Oravec, Research Analyst, The Oxford Club When people think of "safe" dividends, they tend to envision those with single-digit yields. As we've learned here in Safety Net, however, yield isn't what determines dividend safety. A company's free cash flow, payout ratio and dividend track record are much more important. So today we're looking at a company that has a low yield... but is it hitting the right marks when it comes to our grading system? Introducing Baxter International Inc. (NYSE: BAX)... SPONSORED Stock Under $3: Last Value Play on Earth? Last year it was more profitable than Disney, Square or even Tesla... But it's just under $3 per share. It could be $20 a share and STILL be a bargain. Get the Details Here Baxter is a multinational healthcare company focused on treating kidney disease and other acute medical conditions. Founded in 1931, it was the first company to introduce the functioning artificial kidney. And today, the company offers a variety of products, including dialysis therapies, inhaled anesthetics and smart bed systems. With that in mind, investors want to know whether Baxter's 2.75% dividend yield is safe. Let's see if the financials have the right prescription for dividend safety... REVEAL BAX'S DIVIDEND SAFETY RECOMMENDED LINKS One Potentially Explosive Stock That Alexander Green Just Discovered Has Seen Five-Year 2,000% Revenue Growth, Enjoys 70% Gross Margins and Sports a Debt-Free Balance Sheet, yet Still Trades Under $10. He's Calling It the "Next Great American Super Stock." (Click for Details.) Wall Street PROJECTS $30 Energy Stock Will Rise to $280 in 18 Months! MORE FROM WEALTHY RETIREMENT Two Huge Investing Mistakes to Avoid Confessions of a Self-Made Trader The Truth About IPO Investing How to Invest in Pre-IPOs Facebook Twitter Email Share Push Alert SPONSORED "Weird" Savings Account Boost (Seniors Shocked) "Magic Code" FORCES Banks to Pay You Up to 255 Times MORE Cash Interest! (Give This Code to Your Bank ASAP.) Show Me the Code! You are receiving this email because you subscribed to Wealthy Retirement. Wealthy Retirement is published by The Oxford Club. Questions? Check out our FAQs. Trying to reach us? Contact us here. Please do not reply to this email as it goes to an unmonitored inbox. Privacy Policy | Whitelist Wealthy Retirement | Unsubscribe © 2023 The Oxford Club, LLC All Rights Reserved The Oxford Club | 105 West Monument Street | Baltimore, MD 21201 North America: 877.808.9795 | International: +1.443.353.4621 Oxfordclub.com Nothing published by The Oxford Club should be considered personalized investment advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed personalized investment advice. We allow the editors of our publications to recommend securities that they own themselves. However, our policy prohibits editors from exiting a personal trade while the recommendation to subscribers is open. In no circumstance may an editor sell a security before subscribers have a fair opportunity to exit. The length of time an editor must wait after subscribers have been advised to exit a play depends on the type of publication. All other employees and agents must wait 24 hours after publication before trading on a recommendation. Any investments recommended by The Oxford Club should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company. Protected by copyright laws of the United States and international treaties. The information found on this website may only be used pursuant to the membership or subscription agreement and any reproduction, copying or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of The Oxford Club, LLC, 105 West Monument Street, Baltimore, MD 21201.